Clinical trial
Evaluating Pneumococcal Conjugate Vaccine (PCV) Impact on Pneumonia and Pneumococcal Carriage Outcomes in India in Children 1-35 Months in India: Pneumonia Research and Vaccine Impact League
NCT03900520 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Pneumococcal Conjugate Vaccine (PCV) Impact on Pneumonia and Pneumococcal Carriage Outcomes in India in Children 1-35 Months in India: Pneumonia Research and Vaccine Impact League
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 13, 2020
- Completion date
- September 30, 2023
- Enrollment
- 6,004 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.